Last updated on March 2017

Patients needed for migraine study "A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Chronic Migraine"


Brief description of study

Patients needed for migraine study "A Parallel Group, Double-Blind, Randomized, Placebo Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Chronic Migraine"

Detailed Study Description

The purpose of this study is to assess the efficacy and safety of ALD403 in the prevention of migraine headache in chronic migraineurs.

Clinical Study Identifier: TX148044

Contact Investigators or Research Sites near you

Start Over

Patient Recruitment

Cedar Crosse Research Center
Chicago, IL USA
  Connect »